Evidence map›Paper›PMID 12181285›Full record

ArticleThe Journal of physiology2002

Organic cation transporter mRNA and function in the rat superior cervical ganglion.

Doris Kristufek, Walter Rudorfer, Christian Pifl, Sigismund Huck

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. An unsuspected role for organic cation transporter 3 in the actions of amphetamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  5. Review
  6. Review
  7. Decreased anxiety in mice lacking the organic cation transporter 3.Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The SLC22 drug transporter family.Pflugers Archiv : European journal of physiology · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Doris KristufekBrain Research Institute, University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria.
Walter Rudorfer
Christian Pifl
Sigismund Huck
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1). We now demonstrate by single-cell RT-PCR that mRNA of the organic cation transporter 3 (OCT3, uptake 2) occurs in rat SCG neurones as well. Furthermore, our RT-PCR analyses reveal the presence of mRNA for novel organic cation transporters 1 and 2 (OCTN1 and OCTN2), but not for OCT1 or OCT2 in the ganglion. Making use of the NAT as a powerful, neurone-specific transporter system, we loaded[3H]-N-methyl-4-phenylpyridinium ([3H]-MPP+) into cultured rat SCG neurones. The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone. In contrast, cyanine 863 enhanced the radioactive outflow from cultures preloaded with [3H]-NA. Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon: first, the primary radioactive product isolated from supernatants of cultures loaded with [3H]-NA was the metabolite [3H]-DHPG; and second, inhibition of MAO significantly reduced the radioactive outflow in response to cyanine 863. The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters. However, desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP+, indicating the NAT and not an OCT as their primary site of action. The MPP+-induced release of [3H]-MPP+ was fully prevented by a combined application of desipramine and cyanine 863. No trans-stimulation of [3H]-MPP+ outflow was observed by the OCTN1 and OCTN2 substrate carnitine at 100 microM. Our observations indicate an OCT-mediated transmembrane transport of [3H]-MPP+. Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.

Indexed as

1-Methyl-4-phenylpyridiniumAnimalsBiological TransportCarrier ProteinsCatechol O-MethyltransferaseCells, CulturedClorgylineGene ExpressionHerbicidesMembrane ProteinsMethyltransferasesMonoamine OxidaseMonoamine Oxidase InhibitorsNeuronsNorepinephrineOrganic Anion Transporters, Sodium-Independent1-Methyl-4-phenylpyridiniumCarrier ProteinsCatechol O-MethyltransferaseClorgylineHerbicidesMembrane ProteinsMethyltransferasesMonoamine OxidaseMonoamine Oxidase InhibitorsNorepinephrineOrganic Anion Transporters, Sodium-Independentorganic anion transport protein 3Organic Cation Transporter 1Organic Cation Transporter 2Organic Cation Transport ProteinsRNA, MessengerSLC22A2 protein, humanSlc22a2 protein, ratSlc22a4 protein, ratSLC22A5 protein, humanSolute Carrier Family 22 Member 5Solute Carrier ProteinsSymportersTritium

Identifiers

PMID12181285
PMCPMC2290488
OpenAlexW2154270498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.